Loading story…
The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to cause immediate disruption to Indian drugmakers, as the move largely targets…
The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to cause immediate disruption to Indian drugmakers, as the move largely targets branded medicines while exempting generics and biosimilars, said Siddharth Mittal, CEO and Managing Director of Biocon Limited.
Same desk, different stories
The move comes in the wake of Venugopal’s public allegation that fake Aadhaar cards were being produced in CPI(M) Payyanur area committee office as part of a plan to manipulate the electoral process
Inclusion of maps in land transactions and passbooks made mandatory
Christians observed Good Friday with solemn prayers, fasting and religious processions to commemorate the crucifixion of Jesus Christ.
UK AAIB told News18 that it remains in communication with the AAIB India and stands ready to provide additional support and expertise should their investigation require it
Caught senior leadership off guard: Inside the unprecedented wartime firing of US Army Chief Randy George
The police said that Varaaki was originally arrested and remanded to prison a few months ago for allegedly threatening and verbally abusing a woman